SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001753926-23-000492
Filing Date
2023-04-24
Accepted
2023-04-24 15:41:09
Documents
56
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tlcc-20230331.htm   iXBRL 10-Q 1056252
7 EXHIBIT 31.1 ex311_1.htm EX-31.1 12813
8 EXHIBIT 32.1 ex321_2.htm EX-32.1 6979
  Complete submission text file 0001753926-23-000492.txt   5760622

Data Files

Seq Description Document Type Size
2 DEFINITION tlcc-20230331_def.xml EX-101.DEF 180757
3 PRESENTATION tlcc-20230331_pre.xml EX-101.PRE 323505
4 CALCULATION tlcc-20230331_cal.xml EX-101.CAL 64400
5 LABEL tlcc-20230331_lab.xml EX-101.LAB 558301
6 SCHEMA tlcc-20230331.xsd EX-101.SCH 43452
50 EXTRACTED XBRL INSTANCE DOCUMENT tlcc-20230331_htm.xml XML 918760
Mailing Address 4800 T-REX AVENUE SUITE 305 BOCA RATON FL 33431
Business Address 4800 T-REX AVENUE SUITE 305 BOCA RATON FL 33431 561-443-5001
TWINLAB CONSOLIDATED HOLDINGS, INC. (Filer) CIK: 0001590695 (see all company filings)

IRS No.: 463951742 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55181 | Film No.: 23839890
SIC: 2833 Medicinal Chemicals & Botanical Products